300677 英科医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.6022.4063.97258.9341.300
总资产报酬率 ROA (%)2.0141.5772.98844.28087.991
投入资产回报率 ROIC (%)2.1221.6863.27248.96057.952

边际利润分析
销售毛利率 (%)21.89713.69813.12661.50569.029
营业利润率 (%)14.8066.34510.69353.50260.483
息税前利润/营业总收入 (%)10.3521.9711.16753.13762.241
净利润/营业总收入 (%)13.1195.6099.66745.95750.623

收益指标分析
经营活动净收益/利润总额(%)87.21737.29879.851100.121100.207
价值变动净收益/利润总额(%)16.81359.39520.2920.7070.094
营业外收支净额/利润总额(%)-0.7350.864-0.393-0.463-0.267

偿债能力分析
流动比率 (X)1.6111.8113.2445.1653.819
速动比率 (X)1.5031.6772.9264.6483.439
资产负债率 (%)46.04839.82725.27821.82426.997
带息债务/全部投入资本 (%)37.42529.2499.0462.921--
股东权益/带息债务 (%)148.925213.992881.5102,916.383695.989
股东权益/负债合计 (%)115.279148.621291.120352.599267.574
利息保障倍数 (X)-2.382-0.445-0.123-449.92732.448

营运能力分析
应收账款周转天数 (天)44.86238.40036.15814.3200.000
存货周转天数 (天)62.90664.93165.25255.4670.000